Category: Federal

NORML’s Legislative Round Up July 15th, 2016

Members of Congress this week heard testimony on the state of marijuana research, and leading members of the US Senate introduced legislation to potentially reclassify CBD. A medical marijuana initiative in Montana qualified for the November ballot and Governors in three states signed marijuana related bills into law. Click here to get this week’s latest marijuana news and to find out how you can #TakeAction.

NORML’s Weekly Legislative Round Up

State legislators are pre-filing numerous marijuana reform bills in preparation for the start of the 2016 legislative season. Additionally, members of Congress are negotiating on federal funding measures that could have dramatic effects on national marijuana policy. Click here to find out what new legislative reforms are taking place in your state and what the federal budget could mean for you!

NORML Lobby Day One Week Away

The NORML Legislative Fly-In in Washington, DC is one week away. Please join NORML in this call to action.* If you’ve not pre-registered for the May 20th cannabis lobbying training and messaging day, please do ASAP by going here. The conference schedule and speaker list are online. NORML activist and leadership awards, a silent auction and social on Thursday night are all on tap (so to speak…). Marijuana is becoming legal in our lifetimes. Please join us at the nation’s capitol and help hasten these long-needed public policy reforms by […]

Rider in Federal Omnibus Intends to Block DC Legalization

A rider was included in the final version of the House omnibus appropriations bill with the intent blocking the implementation of Washington, DC’s marijuana legalization initiative. As written, the rider seeks to restrict the District from utilizing federal or local funds to “to enact or carry out any law, rule, or regulation to legalize or otherwise reduce penalties associated with the possession, use, or distribution of any schedule I substance under the Controlled Substances Act (21 U.S.C. 801 et seq.) or any tetrahydrocannabinols derivative.” DC’s Initiative 71 was approved by […]